Endosonics(eson) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Endosonics(eson)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Asymmetric who wrote (20)	7/23/1997 6:39:00 AM
From: Sam Quentin	of 205

Peter: <<Yours is the second post on this thread mentioning Johnson & Johnson is interested in taking ESON out. Would make sense for JNJ, but not for ESON. They are technology leader in a sector predicted to grow 40% per year, and just turned profitable last quarter.>> All I know about is Cardometrics and their merger with ESON. I got the information from the Red Chip Review on CFLO. CFLO has a co-distribution agreement with Cordis Corporation, a subsidiary of Johnson & Johson. CFLO will retain its top 40 domestic accounts for the remainder of the year, while Cordis/ J&J will distribute both FloWire and WaveWire tro the remaining domestic accounts. The distribution agreement est monthly, non-cancelable purchase commitments by Cordis/J&J for the remainder of 1997. CFLO trained approx 140 Cordis/J&J sales reps during 2Q97 in prep for a product launch in 3Q97. Red Chip is calling the merger "Arming Intravascular Ultrasound with a Radar Gun...CFLO's FloWire can be used as a tool to help determine whether blood flow was restored immediately after balloon angioplasty, and whether additional intervention (conditional stenting) would be required to restore adequate blood flow." Sam

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next